Skip to main content

Table 3 LDL-TG levels in relation to cardiovascular events in patients with different glucose metabolism status

From: Long-term prognostic utility of low-density lipoprotein (LDL) triglyceride in real-world patients with coronary artery disease and diabetes or prediabetes

LDL-TG

Events/subjects

HR (95% CI)

507/4381

Crude model

Adjusted model

NGR

 Low LDL-TG (T1)

26/378

Ref

Ref

 Medium LDL-TG (T2)

30/296

1.443 (0.853–2.440)

1.491 (0.877–2.535)

 High LDL-TG (T3)

29/252

1.654 (0.974–2.808)

1.663 (0.958–2.866)

Pre-DM

 Low LDL-TG (T1)

54/603

1.278 (0.800–2.040)

1.155 (0.723–1.846)

 Medium LDL-TG (T2)

62/608

1.443 (0.913–2.282)

1.368 (0.859–2.179)

 High LDL-TG (T3)

77/578

1.873 (1.201–2.923)*

1.843 (1.149–2.955)*

DM

 Low LDL-TG (T1)

42/460

1.343 (0.824–2.191)

1.116 (0.682–1.825)

 Medium LDL-TG (T2)

82/581

2.084 (1.341–3.240)*

1.828 (1.165–2.867)*

 High LDL-TG (T3)

105/625

2.457 (1.600–3.775)*

2.212 (1.396–3.507)*

  1. Model adjusted for age, sex, body mass index, smoking, hypertension, diabetes mellitus, family history of early coronary artery disease, Gensini score, left ventricular ejection fraction, LDL-cholesterol, HDL-cholesterol, triglycerides and baseline use of statins; *for p < 0.05